Common use of Length of Study for Participants Clause in Contracts

Length of Study for Participants. You will be in this study for about 44 days. This does not include the time between screening and dosing, which can be up to 28 days. This part of the study involves: • 1 dosing period during 1 continuous admission • 18 overnight stays at the CRU. You will not be able to leave the CRU during that time • 1 follow-up visit about 7 days after the last dose • 1 follow-up phone call about 4 weeks after the last dose

Length of Study for Participants. You will be in this study for about 44 days. This does not include the time between screening and dosing, which can be up to 28 days. This part of the study involves: • 1 dosing period during 1 continuous admission • with 18 overnight stays at the Clinical Research Unit (CRU). You will not be able to leave the CRU during that time • 1 follow-up visit to the CRU about 7 days after the last dose • 1 follow-up phone call about 4 weeks after the last dosedose PART B (Optional) There will be up to 12 people taking part in this part of the study.